Table 3 Details of PMX-DHP and adverse events
|  | PMX-DHP (n = 14, 20 episodes) |
|---|---|
Perfusion duration, 6h/12h | 2/18 |
Cycles of perfusion, 2 times/3 times | 19/1 |
Interval of each perfusion, 12h/18h | 18/2 |
Period from admission to commencement of PMX-DHP, day | 1 (0, 17) |
Adverse events | Pulmonary thromboembolism: 1 |